Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New scrutiny mechanism and re-designation of NBs feature within a much changed EU medtech reg landscape

This article was originally published in Clinica

Executive Summary

The European Commission today published its much awaited proposals for a Regulation on medical devices and another on IVDs. This article looks in more detail at some of the far-reaching measures in the proposed medical devices Regulation and its impact on companies and other stakeholders in the medtech industry. Amanda Maxwell reports

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel